Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Award | $801K | +3.29K | +12.22% | $243.27 | 30.2K | Feb 9, 2022 | Direct | |
holding | LLY | Common Stock | 514 | Feb 9, 2022 | 401(k) | ||||||
holding | LLY | Common Stock | 128 | Feb 9, 2022 | by partner | F1 | |||||
holding | LLY | Common Stock | 2.68K | Feb 9, 2022 | 401(k) - by partner | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Award | $0 | +2.1K | $0.00 | 2.1K | Feb 9, 2022 | Common Stock | 2.1K | Direct | F2 |
Id | Content |
---|---|
F1 | Reporting person disclaims beneficial ownership of these shares. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |